GlaxoSmithKline Denied Bid To Unpause Philly Paxil Litigation

Law360, Philadelphia (July 15, 2016, 8:27 PM EDT) -- A Pennsylvania state judge has refused GlaxoSmithKline's bids to lift a stay on litigation over birth defects allegedly caused by the antidepressant Paxil that was imposed after evidentiary concerns ended one case mid-trial in April.

Philadelphia County Court of Common Pleas Judge Arnold New on Tuesday entered one-page orders in seven cases denying Paxil-manufacturer GlaxoSmithKline’s requests to lift a stay over mass tort litigation that was entered in April until a final conclusion is reached in the initial case, which is currently being appealed.

GSK had...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.